Literature DB >> 23577898

Treating opioid use disorders during pregnancy: historical, current, and future directions.

Hendrée E Jones1.   

Abstract

The historical and current contexts of opioid use disorders during pregnancy are reviewed. There has been a long history of use of opioids by women in the United States, including by prescription prior to 1919. Neonatal abstinence syndrome was first identified coincident with this use. Methadone and more recently buprenorphine have proven to be successful pharmacotherapeutic agents in the treatment of opioid use disorder in pregnant women. However, these medications should be seen as only one ingredient of a comprehensive treatment approach for this population. The 21st century needs to witness a heightened emphasis on the myriad factors that lead to opioid use in women, and a broader education of those professionals who may come in contact with pregnant women with opioid use disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23577898     DOI: 10.1080/08897077.2012.752779

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  4 in total

1.  Clinical correlates of prescription opioid analgesic use in pregnancy.

Authors:  Megan V Smith; Darce Costello; Kimberly A Yonkers
Journal:  Matern Child Health J       Date:  2015-03

2.  Characteristics and quality of life of opioid-dependent pregnant women in Austria.

Authors:  Verena E Metz; Sandra D Comer; Johanna Wuerzl; Anna Pribasnig; Gabriele Fischer
Journal:  Arch Womens Ment Health       Date:  2014-07-15       Impact factor: 3.633

3.  A woman's experience of tapering from buprenorphine during pregnancy.

Authors:  Gabrielle Katrine Welle-Strand; Odd Kvamme; Andreas Andreassen; Edle Ravndal
Journal:  BMJ Case Rep       Date:  2014-12-24

4.  Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics.

Authors:  Ariadna Forray; Amanda Mele; Nancy Byatt; Amalia Londono Tobon; Kathryn Gilstad-Hayden; Karen Hunkle; Suyeon Hong; Heather Lipkind; David A Fiellin; Katherine Callaghan; Kimberly A Yonkers
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.